3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Thoracic
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colorectal Neoplasms
1431
Pancreatic Neoplasms
664
Colonic Neoplasms
655
Carcinoma, Hepatocellular
632
Rectal Neoplasms
571
Stomach Neoplasms
547
Esophageal Neoplasms
384
Liver Neoplasms
280
Breast Neoplasms
278
Neoplasms
243
Gastrointestinal Neoplasms
214
Lung Neoplasms
175
Prostatic Neoplasms
137
Barrett Esophagus
127
Colonic Polyps
115
Cholangiocarcinoma
114
Motor Activity
101
Ovarian Neoplasms
75
Head and Neck Neoplasms
73
Neoplasm Metastasis
64
Adenoma
61
Uterine Cervical Neoplasms
58
Anus Neoplasms
54
Anastomotic Leak
54
Carcinoma, Non-Small-Cell Lung
53
Colorectal Neoplasms, Hereditary Nonpolyposis
51
Biliary Tract Neoplasms
51
Postoperative Complications
49
Urinary Bladder Neoplasms
47
Esophageal Squamous Cell Carcinoma
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Atrial Fibrillation
×
Gastrointestinal
×
Clear all
NCT04331535
2022-10-03
GenoVA
Boston VA Research Institute, Inc.
Phase NA
Unknown
1,076 enrolled